United States · Platforms & data · Stocktwits

Compass Pathways To Complete COMP360 FDA Filing Within Two Weeks — CEO Nath Eyes Launch In First Half Of 2027

Published by Stocktwits · United States 12 h ago

The drugmaker reported a diluted net loss of $0.31 per share in Q3, beating analysts’ expectations of a $0.41 per share loss, according to Fiscal.ai. Compass ended September with…

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

The Motley Fool

Why Did Bloom Energy Stock Jump 10% Today?

MarketWatch

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Yahoo Finance

Colorado homeowners face $7,000 to $20,700 HOA special assessments for hail-damaged roofs — or risk foreclosure

CNBC

Morgan Stanley's Ariana Salvatore on U.S. midterms: Executive policy is the story for markets

TheStreet

Analyst sends big warning on gold and bitcoin amid U.S. midterms

TipRanks